According to the FMI report, the global pelvic floor stimulators industry is poised to achieve sales of US$ 140.39 million in 2023. Furthermore, the demand outlook remains highly positive, with an expected Compound Annual Growth Rate (CAGR) of 8.8% from 2023 to 2033. The market is projected to reach a remarkable US$ 325.41 million by the end of this period.
Pelvic floor stimulators are increasingly recommended for patients dealing with urologic disorders such as cystitis, urinary retention, kidney stones, and benign prostatic hyperplasia. Notably, the Asia Pacific region, including countries like China, India, and Japan, is witnessing a surge in the elderly population facing urinary issues, leading to an escalated demand for these devices.
Request a Sample copy of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13187
The growth of the industry can be attributed to significant research and development efforts in pelvic floor stimulators. These devices play a crucial role in providing robust therapies for treating weak pelvic floor muscles and stress urinary incontinence. The commitment to innovation is evident through the substantial investments made by key industry players, which are expected to propel market development in the coming decade.
FMI is well-positioned to capitalize on this growth trend, leveraging its expertise and commitment to advancing healthcare solutions. With a strong focus on research and development, FMI aims to contribute to the evolution of pelvic floor stimulators, ensuring effective and innovative solutions for patients worldwide.
As a key player in the healthcare industry, FMI remains dedicated to meeting the evolving needs of healthcare professionals and patients alike. The company is confident that its contributions will play a vital role in shaping the future landscape of pelvic floor stimulators, ultimately improving the quality of life for those facing urologic challenges.
Top Highlights from the FMI’s Analysis of the Pelvic Floor Stimulators Market:
- The United States pelvic floor stimulators industry presently shares around 76% of the North American region.
- Over the forecast period, the United Kingdom’s pelvic floor stimulators industry is anticipated to expand at a CAGR of 8.7%.
- In 2022, the India pelvic floor stimulators industry crossed 55% of sales recorded in South Asia.
- The Australian market is projected to represent a CAGR of 10.6% in the forecast period.
- The electrical stimulators segment is projected to register a CAGR of 9.1% over the upcoming years.
- The hospital segment significantly contributed to overall market growth. From 2023 to 2033, the segment is projected to record a CAGR of 9.2%.
How are Industry Players Increasing their Foothold in the Market?
Competitors providing pelvic floor stimulators are introducing innovations to invigorate their product portfolios. By releasing technologically advanced products, the companies are targeting potential customers. Additionally, the firms are engaging in mergers and acquisitions to support their market position. By implementing these strategies, companies can boost their capacity, multiply their product portfolio, and enhance device competency.
Following are Some Recent Developments in the Market:
- Product Launch
Zynex, an electrotherapy devices manufacturer launched NeuroMove in February 2018. The product is aimed at survivors of stroke who seek to regain their movement using neuroplasticity.
- Acquisition
Laborie, a medical technology company completed the acquisition of Clinical Innovations in February 2020. The acquisition was completed for US$ 525 million. Through this acquisition, the company projected to invigorate its foothold in the market.
Act Now to Explore In-Depth Market Analysis: Get Exclusive Discount Now to Access Market Insights: https://www.futuremarketinsights.com/checkout/13187
Key Players in the Market:
- Medtronic Plc
- Atlantic Therapeutics
- Laborie Inc.
- The Prometheus Group
- Everyway Medical Instruments Co., Ltd.
- KayCo 2 Ltd.
- InControl Medical Ltd.
- Tic Medizintechnik GmbH
- Shenzhen XFT Medical Ltd.
- Chiaro Technology Ltd.
- Zynex Inc.
- Utah Medical Products, Inc.
- Verity Medical Ltd.
Pelvic Floor Stimulators Industry by Category:
Product Type:
- Electrical stimulators
- Magnetic Stimulators
Application:
- Urinary Incontinence
- Sexual Dysfunction
- Neurodegenerative Diseases
End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialized clinics
- Homecare setting
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
Female Pelvic Implants Market Size: The female pelvic implants market is projected to account for sales worth US$ 258.91 million by 2023. The market is projected to observe a CAGR of 2.8% in the forecast period, reaching US$ 341.26 million by 2033.
Bone Growth Stimulators Market Share: The bone growth stimulators market size is projected to be valued at US$ 2.1 billion in 2023 and is expected to rise to US$ 5.4 billion by 2033. The sales of bone growth stimulators are expected to grow at a significant CAGR of 10.1% during the forecast period.
Spinal Cord Stimulators Market Growth: The spinal cord stimulators market size is estimated to register a revenue of US$ 5,441.4 million by 2033. Our healthcare experts opine that spinal cord stimulator suppliers can expect a promising CAGR of 7.2% through 2033, with a present valuation of US$ 2,702.7 million in 2023.
Pelvic Floor Diagnostics Market Demand: The overall valuation of the pelvic floor diagnostics market is projected to total US$ 2,056.74 million in 2023. By the end of 2033, the market is estimated to equal US$ 3,753.39 million, recording a CAGR of 6.2%.
Bowel Stimulators Market Outlook: According to the latest research by Future Market Insights, Bowel Stimulators market is set to witness a 6.3% growth during the year 2021-2031.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
